Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy
- Author(s)
- Wei, AH; Panayiotidis, P; Montesinos, P; Laribi, K; Ivanov, V; Kim, I; Novak, J; Champion, R; Fiedler, W; Pagoni, M; Bergeron, J; Ting, SB; Hou, JZ; Anagnostopoulos, A; McDonald, A; Murthy, V; Yamauchi, T; Wang, J; Jiang, Q; Sun, Y; Chyla, B; Mendes, W; DiNardo, CD;
- Details
- Publication Year 2022-12-22,Volume 140,Issue #25,Page 2754-2756
- Journal Title
- Blood
- Publication Type
- Research article
- Keywords
- Humans; Follow-Up Studies; *Leukemia, Myeloid, Acute/drug therapy/etiology; Cytarabine; Antineoplastic Combined Chemotherapy Protocols
- Department(s)
- Haematology
- PubMed ID
- 36112968
- Publisher's Version
- https://doi.org/10.1182/blood.2022016963
- Open Access at Publisher's Site
https://doi.org/10.1182/blood.2022016963- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-05-09 06:08:23
Last Modified: 2025-05-09 06:09:24